Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegasys with Adefovir or Entecavir Lead-in in HBeAg+ Chronic Hepatitis B
NCT00922207Phase 4Completed
- Sponsor
- Roche
- Start
- May 2010
- Primary completion
- Sep 2014
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of peginterferon alfa-2a in Chronic Hepatitis B (CHB), sponsored by Roche. Started May 2010; status: completed.
02
Drugs
peginterferon alfa-2a
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00922207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00922207.